• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Agios Pharmaceuticals, Inc. (AGIO)

    -NasdaqGS
    90.69 Up 0.67(0.74%) Aug 28, 4:00PM EDT
    |After Hours : 90.62 Down 0.07 (0.08%) Aug 28, 4:42PM EDT
    Add to Portfolio
    Prev Close:90.02
    Open:89.47
    Bid:0.00 x 100
    Ask:91.30 x 200
    1y Target Est:123.89
    Beta:0.937394
    Earnings Date:Nov 5 - Nov 9 (Est.)
    Day's Range:88.79 - 91.75
    52wk Range:41.86 - 138.85
    Volume:319,416
    Avg Vol (3m):608,888
    Market Cap:3.40B
    P/E (ttm):N/A
    EPS (ttm):-1.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AGIO

    Comparison

    Symbol% ChgMkt Cap
    AGIOUp 0.74%3.40B
    ALXNDown 0.53%40.45B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):35.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.34
    Quarterly EPS Est (Sep-15) :-0.88
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback